| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/31/2000 | EP1003776A1 Gene and amino acid sequences for novel transcription factor |
| 05/31/2000 | EP1003775A2 Hepatitis c inhibitor peptides |
| 05/31/2000 | EP1003773A1 Ctl epitopes from ebv |
| 05/31/2000 | EP1003772A1 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 05/31/2000 | EP1003770A1 Secreted proteins and polynucleotides encoding them |
| 05/31/2000 | EP1003769A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 05/31/2000 | EP1003768A1 Secreted proteins and polynucleotides encoding them |
| 05/31/2000 | EP1003767A1 Human tumor necrosis factor receptor tr10 |
| 05/31/2000 | EP1003766A1 Tumor surface protein and its complementary surface receptor on naive natural killer cells |
| 05/31/2000 | EP1003763A1 83 human secreted proteins |
| 05/31/2000 | EP1003570A1 Osteopontin coated surfaces and methods of use |
| 05/31/2000 | EP1003549A1 IMMUNOGENIC CONJUGATES COMPRISING A GROUP B MENINGOCOCCAL PORIN AND AN $i(H. INFLUENZAE) POLYSACCHARIDE |
| 05/31/2000 | EP1003548A1 A method of inducing a ctl response |
| 05/31/2000 | EP1003545A1 Heparin-binding growth factor (hbgf) polypeptides |
| 05/31/2000 | EP1003544A1 C1q AND COLLECTIN RECEPTOR |
| 05/31/2000 | EP1003543A1 Apoptosis-inducing gelsolin sequences |
| 05/31/2000 | EP1003539A1 FLUORESCENT AMYLOID A$g(b) PEPTIDES AND USES THEREOF |
| 05/31/2000 | EP1003480A1 Conjugated peptide nucleic acids having enhanced cellular uptake |
| 05/31/2000 | EP1003377A1 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(PSEUDOMONAS SYRINGAE) AND ITS USE |
| 05/31/2000 | EP1003372A1 A nod factor binding protein from legume roots |
| 05/31/2000 | EP1003365A1 Atrial natriuretic factor mutants and ischemic stroke |
| 05/31/2000 | EP1003364A1 Germplasm and molecular markers for disease resistance in potato |
| 05/31/2000 | EP1003363A1 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(ERWINIA AMYLOVORA), ITS USE, AND ENCODING GENE |
| 05/31/2000 | EP1003362A1 Hypersensitive response elicitor from erwinia amylovora and its use |
| 05/31/2000 | EP0944650B1 Antithrombotic peptides derived from fibronectin type ii repeats |
| 05/31/2000 | EP0861093B1 Non-invasive Detection of the Integration of a Transgene in Mammals |
| 05/31/2000 | EP0811056B1 Peptides for tissue and cell culture media |
| 05/31/2000 | EP0791013B1 Methods and compositions for screening for presynaptic calcium channel blockers |
| 05/31/2000 | EP0746337B1 Verotoxin pharmaceutical compositions and medical treatments thereof |
| 05/31/2000 | EP0673383B1 Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same |
| 05/31/2000 | EP0643778B1 Encoded combinatorial chemical libraries |
| 05/31/2000 | EP0635016B1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof |
| 05/31/2000 | EP0584082B1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 05/31/2000 | EP0464022B1 Insulinotropic hormone |
| 05/31/2000 | CN1255166A Method for integrating genes at specific sites in mammalian cells via homologous recombination and used carrier |
| 05/31/2000 | CN1255143A Novel strain of bacillus for controlling plant diseases and corn rootworm |
| 05/31/2000 | CN1255140A An infections clone for human parainfluenza virus type 3 |
| 05/31/2000 | CN1255044A Orally active fraction of momordica charactia, active peptides thereof, and their use in the treatment of diabetes |
| 05/31/2000 | CN1254756A Attenuated virus of ox's viral diarrhea |
| 05/31/2000 | CN1254718A Active peptide |
| 05/31/2000 | CN1053013C Cloning and expression of microbial phytase |
| 05/31/2000 | CN1053012C Hog choera virus vaccine and diagnostic |
| 05/30/2000 | US6070126 Immunobiologically-active linear peptides and method of identification |
| 05/30/2000 | US6069301 Antibodies which bind to insect gut proteins and their use |
| 05/30/2000 | US6069296 Regulators of G-protein signalling |
| 05/30/2000 | US6069242 Mixture of pharmaceutically acceptable carrier and antisense nucleic acid; for diagnosis, imaging, anticarcinogenic agents, antitumor agents |
| 05/30/2000 | US6069241 Amino acid and nucleotide sequences of gene expressed specifically at initial stages in flower-bud growth; for controlling plant flowering |
| 05/30/2000 | US6069239 Expression system present in compatible host cell which produces a ligand regulated transcription factor; antiinflammatory/antiarthritic/antidiabetic agents; treatment of autoimmune diseases; diagnosis of related diseases |
| 05/30/2000 | US6069235 Method for carbohydrate engineering of glycoproteins |
| 05/30/2000 | US6069233 Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof |
| 05/30/2000 | US6069231 Amino acid sequences of domains found in transcription factors including a mammalian retinoblastoma-interacting zinc finger protein; for fusion proteins useful for regulating transcription of target genes; diagnosis of related diseases |
| 05/30/2000 | US6069230 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 05/30/2000 | US6069193 Administering an effective amount of transferrin to a mammal suffering from type ii diabetes mellitus |
| 05/30/2000 | US6069134 Methods and compositions comprising DNA damaging agents and p53 |
| 05/30/2000 | US6069129 Elastin derived composition and method of using same |
| 05/30/2000 | US6069128 Low molecular weight peptide corresponding to transmembrane region of interleukin-8 protein, transformed into its acetoxymethyl ester counterpart and converted back to orginal form via intracellular esterase; treating inflammation |
| 05/30/2000 | US6069127 Human infant formula containing a glycoprotein specific for binding to the human mac-2 (macrophage antigen) lectin; to prevent infections |
| 05/30/2000 | US6069006 Connective tissue growth factor (CTGF) regulatory nucleic acid sequences |
| 05/30/2000 | US6069001 Nucleotide sequence; for use in diagnosis of cancer and melanoma; for use in human leukocyte antigen typing for grafts and transplants |
| 05/30/2000 | US6068995 Method for producing protein |
| 05/30/2000 | US6068994 Expression of heterologous proteins in yeast using dna encoding a fusion protein of ubiquitin and the protein which is cleaved in vivo by an endogenous ubiquitin-specific hydrolase to yield protein with authentic n-terminal |
| 05/30/2000 | US6068993 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 05/30/2000 | US6068992 Production of gonorrheal PI proteins and vaccines |
| 05/30/2000 | US6068991 High expression Escherichia coli expression vector |
| 05/30/2000 | US6068985 In vitro test for Helicobacter pylori |
| 05/30/2000 | US6068984 Separating hb15 prositive cells from population of unrelated cells by reacting antibody that specifically binds the extracellular, transmembrane or cytoplasmic domain of the glycoprotein, then isolating cells |
| 05/30/2000 | US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease |
| 05/30/2000 | US6068976 Nucleotide sequences of control region of human obesity gene; for screening modulators of gene expression to treat hypertension, cardiovascular diseases, diabetes, infertility, obesity, anorexia, cachexia, and other eating disorders |
| 05/30/2000 | US6068973 Suppressing transmission of influenza a virus to cell by contacting cell with influenza virus peptide of specific sequence chosen by a computer algorithm |
| 05/30/2000 | US6068972 Screening by contacting microorganisms with organic solvent, determining expression of acr-like efflux pump gene locus, comparing to control, altered expression indicates activation of multiple antibiotic resistance phenotype |
| 05/30/2000 | US6068843 An amount of a 56 kda polypeptide encoded by a 2.3 kb hindiii partial digest restriction fragment of serpulina hyodysenteriae b204 effective to produce a protective immune respone against serpulina hyodysenterie infection in swine |
| 05/30/2000 | US6068842 A polypeptide containing 66 kda protein of borrelia afzelli |
| 05/30/2000 | US6068841 Antibodies to Fas-L for treatment of hepatitis |
| 05/30/2000 | US6068838 Purified multimerase having proteolytic activity, converts von willebrand factor having a singlet structure to von willebrand factor having satellite structure and is active in presence of serine protease and calpin protease inhibitor |
| 05/30/2000 | US6068837 Mesothelial cell gene therapy |
| 05/30/2000 | US6068836 Providing a population of pluripotent hematopoetic cells, expanding population of stem cells to yield expanded stem cells, inducing a majority of cells in the population of expanded cells to become quiescent, using quiescent cells |
| 05/30/2000 | CA2676762A1 Peptides for the detection of hiv-1 group o |
| 05/30/2000 | CA2181566C Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 05/30/2000 | CA2158274C Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| 05/30/2000 | CA2153071C Derivatized calcitonins |
| 05/30/2000 | CA2142862C Method for inhibiting hiv replication using il-4 |
| 05/30/2000 | CA2092953C Enzymatic hydrolysis |
| 05/30/2000 | CA2063416C Methods of treating or preventing autoimmune uveoretinitis mammals |
| 05/30/2000 | CA2045200C Immobilization of biomolecules by enhanced electophoretic precipitation |
| 05/30/2000 | CA2044630C Subtilisin mutants |
| 05/30/2000 | CA2026570C Method for production and purification of hepatitis b vaccine |
| 05/30/2000 | CA2019363C Dna and use thereof |
| 05/30/2000 | CA1341004C Recombinant alzheimer's amyloid protein |
| 05/26/2000 | CA2252967A1 Protein fragments for use in protein targeting |
| 05/26/2000 | CA2252966A1 Viral therapeutics |
| 05/25/2000 | WO2000029846A2 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY |
| 05/25/2000 | WO2000029626A1 Rhadino virus lana acts in trans on a unit of rhadino virus dna to mediate efficient episome persistence |
| 05/25/2000 | WO2000029625A1 Identification of differentially methylated multiple drug resistance loci |
| 05/25/2000 | WO2000029623A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/25/2000 | WO2000029622A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/25/2000 | WO2000029621A2 Method for measuring target polynucleotides and novel asthma biomolecules |
| 05/25/2000 | WO2000029614A1 Human prostaglandin receptors and methods of use thereof |
| 05/25/2000 | WO2000029608A1 Transgenic animals as urinary bioreactors for the production of protein in the urine, recombinant dna construct for kidney-specific expression, and method of using same |
| 05/25/2000 | WO2000029607A1 Novel enhancers of plant growth |
| 05/25/2000 | WO2000029595A1 Pad4 compositions and methods therefor |